Subscribe to Newsletter

Business & Regulation

Business & Regulation Business Practice

Never Break the Chain

| Nadine Lampka | 5 min read

How do we prevent criminals from reusing primary packaging for counterfeit medicines? Labeling solutions and other creative concepts can help.

Business & Regulation Standards & Regulation

MSD Files Lawsuit Against US Government

| Stephanie Vine | 4 min read

MSD describes drug price negotiation program as “sham” and “tantamount to extortion”

Business & Regulation Standards & Regulation

FDA Warning Letters: May 2023 Edition

| Stephanie Vine | 4 min read

Misbranded drugs, unapproved drugs, and companies who don’t know that ophthalmic drugs should be manufactured in a sterile environment…

Business & Regulation Business Practice

What’s Going On With Amgen and Horizon Therapeutics?

| Stephanie Vine | 2 min read

Amgen’s planned acquisition of Horizon Therapeutics has hit a bump in the road.

Business & Regulation Business Practice

The Price of the PBM

| Mallikarjun Chityala | 5 min read

There are many players in pharmaceutical pricing, from drug manufacturers to PBMs and pharmacies. Who should take the lead?

Business & Regulation Business Practice

An Alliance of Giants

| Rob Coker | 4 min read

Hall Gregg, Chief Portfolio Officer at the Pistoia Alliance, discusses the transformative power of collaboration, innovation, and diversification

Business & Regulation Trends & Forecasts

Tap the App

| Francesco Patalano | 4 min read

What can science learn from patients, and how can patients benefit from being in control of their own health?

Business & Regulation Trends & Forecasts

Patient-Centric Perspectives

| Keri Yale | 5 min read

Patient-centricity needs to be more than a buzzword. Here’s how Boehringer Ingelheim is weaving it into its culture.

Business & Regulation Profession

The Power List 2023 Is Live

| Stephanie Vine

The wait is over. Our annual celebration of the pharma industry’s most influential individuals has returned!

Business & Regulation Profession

Notes on Disparity from a Female CEO

| Vineeta Tripathi | 7 min read

Do investors scrutinize pharma CEOs more closely when they are women?

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register